Stemtech Corporation
STEK · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $4 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $4 | $4 | $4 |
| Enterprise Value | $4 | $8 | $8 | $9 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 22.1% | -19.6% | -33.9% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 80.1% | 79.1% | 83% | 79.6% |
| EBITDA | -$0 | -$0 | -$1 | $0 |
| % Margin | -25.1% | -25% | -135% | 11.9% |
| Net Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -0.4% | -42% | -167.7% | -30.2% |
| EPS Diluted | -0.01 | -0.002 | -0.01 | -0.003 |
| % Growth | -376.2% | 79% | -244.8% | – |
| Operating Cash Flow | $0 | $0 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | -$1 | -$1 |